SynthesisFrontiers in immunology2025

Integrating clinical trial landscapes and bibliometric analysis: unveiling the impact of PD-1/PD-L1 inhibitors on renal cell carcinoma research and therapeutic trajectories summary.

Yuanbin Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.